VELLA, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 1.335
EU - Europa 1.134
AS - Asia 412
SA - Sud America 5
OC - Oceania 4
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.893
Nazione #
US - Stati Uniti d'America 1.288
IE - Irlanda 386
UA - Ucraina 284
GB - Regno Unito 115
SG - Singapore 114
CN - Cina 111
HK - Hong Kong 104
DE - Germania 88
IT - Italia 73
SE - Svezia 51
FI - Finlandia 48
CA - Canada 47
IN - India 46
CH - Svizzera 42
BE - Belgio 17
IL - Israele 10
TR - Turchia 9
IR - Iran 8
ES - Italia 7
EE - Estonia 6
FR - Francia 5
AU - Australia 3
BR - Brasile 3
JP - Giappone 3
NL - Olanda 3
CZ - Repubblica Ceca 2
IQ - Iraq 2
KR - Corea 2
NG - Nigeria 2
AR - Argentina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
EU - Europa 1
IS - Islanda 1
LI - Liechtenstein 1
NZ - Nuova Zelanda 1
OM - Oman 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
RO - Romania 1
RU - Federazione Russa 1
VE - Venezuela 1
Totale 2.893
Città #
Dublin 386
Chandler 263
Jacksonville 252
Boardman 110
Hong Kong 104
London 104
Singapore 69
Wilmington 68
Beijing 48
Helsinki 48
Dearborn 46
Chicago 44
Toronto 42
Zurich 42
San Mateo 29
Capo D'orlando 27
Princeton 27
Ashburn 22
Ann Arbor 19
Brussels 17
Falls Church 16
Leawood 16
Padova 14
Azor 10
New Orleans 10
Augusta 9
Hefei 9
Kunming 9
Norwalk 9
Edinburgh 8
Monmouth Junction 8
Catania 7
Istanbul 7
Madrid 7
Munich 7
Milan 6
Tallinn 6
Los Angeles 5
Pune 5
Messina 4
Nanchang 4
Ardabil 3
Bangalore 3
Des Moines 3
Guangzhou 3
Gunzenhausen 3
Jaipur 3
Nanjing 3
Wuhan 3
Atlanta 2
Basra 2
Cambridge 2
Falkenstein 2
Frankfurt am Main 2
Hangzhou 2
Jinan 2
Kocaeli 2
Kurosunadai 2
Kyiv 2
Lagos 2
Montreal 2
Mumbai 2
New York 2
Rome 2
Seattle 2
Seoul 2
Shenyang 2
Sydney 2
Amsterdam 1
Auckland 1
Bandar Seri Begawan 1
Borås 1
Bremen 1
Brno 1
Bucharest 1
Changsha 1
Chongqing 1
Fuzhou 1
Henderson 1
Houston 1
Jinhua 1
Jining 1
Lanzhou 1
Lisbon 1
Ningbo 1
Nuremberg 1
Olomouc 1
Ottawa 1
Paris 1
Patos de Minas 1
Pirenópolis 1
Rawalpindi 1
Reykjavik 1
Salalah 1
Salvador 1
San Miguel de Tucumán 1
Shanghai 1
Shaoxing 1
Shenzhen 1
Sofia 1
Totale 2.037
Nome #
The p53-homologue p63may promote thyroid cancer progression 124
TAp63α antagonizes p53 oncosuppressor function in thyroid cancer cells 120
p53 family proteins in thyroid cancer 112
p73 Tumor-Suppressor Activity is Impaired in Human thyroid Cancer 108
TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation 108
Insulin Receptor Isoforms and Insulin-Like Growth Factor Receptor in Human Follicular Cell Precursors from Papillary Thyroid Cancer and Normal Thyroid 89
Metabolic alterations of thyroid cancer as potential therapeutic targets 84
P73 tumor-suppressor activity is impaired in human thyroid cancer 76
BRAF(V600E) mutation and the biology of papillary thyroid cancer 72
Interleukin-4 stimulates papillary thyroid cancer cell survival: implications in patients with thyroid cancer and concomitant Graves' disease 69
Novel cross-talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses 66
Anaplastic Thyroid Cancer in Sicily: The Role of Environmental Characteristics 64
The IGF system in thyroid cancer:new concepts 62
Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer? 61
Insulin/IGF-I hybrid receptors play a major role in IGF-I signaling in thyroid cancer 60
Immunostaining for MET/HCF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy 60
DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells 59
Exclusion of c-Abl from the Nucleus Restrains the p73 Tumor Suppression Function 58
IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway 57
TAp73 Increases tumor suppressor activity in thyroid cancer cells via the inhibition of mdm2-mediated degradation 56
Levels of histone acetylation in thyroid tumors. 55
Thyrospheres From Normal or Malignant Thyroid Tissue Have Different Biological, Functional, and Genetic Features 54
Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells 53
Reactivation of p53 mutants by p53 reactivation and induction of massive apoptosis in thyroid cancer cells 52
Tyrosine kinase inhibitor STI571 enhances thyroid cancer cell motile response to Hepatocyte Growth Factor 51
PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis 49
Thyrospheres: a new in vitro model for testing human thyroid endocrine disruptors 47
Insulin Receptor Isoforms in Physiology and Disease: An Updated View 44
A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer 43
Recent views of heavy metals as possible risk factors and potential preventive and therapeutic agents in prostate cancer 42
Il BRAF(V600E) è responsabile della resistenza delle cellule di carcinoma tiroideo al Gefitinib 38
miRNA upregulation in thyroid cancer is caused by the inhibition of the p53 pathway 37
null 33
Identification of Thyroid Cancer Stem Cells 32
null 29
null 29
The expression of PTEN tumor suppressor is down regulated by dominant negative p73 isoform ΔNp73 in thyroid cancer cells 29
null 27
Sporadic and Familial Medullary Thyroid Carcinoma: A Retrospective Single Center Study on Presentation and Outcome 26
null 26
Isolation of thyroid cancer stem cells 26
Regulation of miRNAs by p53 family members in thyroid cancer cells 26
null 25
null 25
null 25
null 25
null 24
null 24
Genome wide analysis in papillary thyroid carcinoma 24
Effetto del trattamento epigenetico combinato di acido valproico e 5-Azacitidina in un modello di carcinomi della Tiroide poco differenziati 24
null 23
Reactivation of p53 mutants by small compounds may represent an adjuvant therapy of poorly differentiated thyroid cancer 23
Thyrospheres an in vitro model for human thyroid carcinogenesis 23
In IGF-IR deficient leiomyosarcoma cells IGF-II stimulates biological effects via the insulin receptor isoform A 23
null 22
null 22
Role of Braf (v600) mutation in the resistance to Gefitinib of thyroid cancer cells. 22
Activation of the s100a7/rage pathway by igf-1 contributes to angiogenesis in breast cancer 21
null 21
COVID-19 and Diabetes: The Importance of Controlling RAGE 18
RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer 17
Insulin/IGF axis and the Receptor for Advanced Glycation End Products: role in meta-inflammation and potential in cancer therapy 16
Inflammasome activation as a link between obesity and thyroid disorders: Implications for an integrated clinical management 10
Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress 10
Ddr1 affects metabolic reprogramming in breast cancer cells by cross-talking to the insulin/igf system 10
IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance? 9
Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells 9
Editorial: Early diagnoses and treatments of uncommon breast cancers 8
IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance? 7
Thyroid cancer cell resistance to gefitinib depends on the constitutive oncogenic activation of the ERK pathway. 7
Microenvironmental Determinants of Breast Cancer Metastasis: Focus on the Crucial Interplay Between Estrogen and Insulin/Insulin-Like Growth Factor Signaling 6
Onset of Marine-Lenhart syndrome and Graves’ ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis 6
IFN-I signaling in cancer: the connection with dysregulated Insulin/IGF axis 6
null 2
Totale 2.950
Categoria #
all - tutte 20.401
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.401


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020270 0 0 0 0 27 61 48 60 18 9 47 0
2020/2021487 45 0 42 42 0 43 0 108 44 44 76 43
2021/2022267 0 0 4 69 9 25 3 59 21 27 15 35
2022/2023854 62 19 29 121 128 108 14 104 122 26 99 22
2023/2024634 40 76 46 27 71 24 86 26 23 24 119 72
2024/2025276 49 60 88 36 43 0 0 0 0 0 0 0
Totale 2.950